138 results
Page 4 of 7
8-K
EX-99.1
2t8dmk7o
6 Aug 20
FibroGen Announces New Appointments to its Board of Directors
4:06pm
8-K
EX-99.1
3kqid6te7ow9lc8i
7 May 20
FibroGen Reports First Quarter 2020 Financial Results
4:09pm
8-K
EX-99.1
pg1 9wwn4p5n
2 Mar 20
FibroGen Reports Fourth Quarter and Full Year 2019 Financial Results
4:06pm
8-K
EX-99.1
2ax5 htsb
11 Feb 20
FibroGen Announces U.S. FDA Acceptance of New Drug Application for Roxadustat for the Treatment of Anemia of Chronic Kidney Disease
5:16pm
8-K
EX-99.1
xifh 59pug466
30 Jan 20
Astellas Submits Supplemental New Drug Application for Approval of
4:40pm
8-K
EX-99.1
kojasne46o2t3u3asfe8
13 Jan 20
Regulation FD Disclosure
9:01am
8-K
EX-99.1
tkg1ecbx1ygs
6 Jan 20
Fibrogen Names Enrique Conterno As Chief Executive Officer
5:23pm
8-K
EX-99.1
aszsclguigyiwzgz
23 Dec 19
Fibrogen Submits New Drug Application to the U.S. Fda for Roxadustat In Patients with Anemia of Chronic Kidney Disease
9:06am
8-K
EX-99.1
e85fe79zfkx jz
2 Dec 19
FibroGen Announces Roxadustat Inclusion in China’s National Reimbursement Drug List
7:10am
8-K
EX-99.2
40xfv83y3j75e1s83eiz
12 Nov 19
FibroGen Reports Third Quarter 2019 Financial Results
8:16am
8-K
EX-99.1
9mlcmuec1ya7
12 Nov 19
FibroGen Reports Third Quarter 2019 Financial Results
8:16am
8-K
EX-99.1
3381jgcbzf8yxv6
8 Nov 19
Regulation FD Disclosure
2:05pm
8-K
EX-99.1
qx4cui
8 Nov 19
FibroGen Announces Positive Phase 3 Pooled Roxadustat Safety and Efficacy Results for Treatment of Anemia in Chronic Kidney Disease
2:00pm
8-K
EX-99.1
ccyk1g ios9yr
11 Oct 19
Regulation FD Disclosure
11:49am
8-K
EX-99.1
9akfw0jn8b5
26 Sep 19
FibroGen Announces Initiation of Phase 2 Clinical Trial of Roxadustat for the Treatment
9:01am
8-K
EX-99.1
i08loz3u8 ca30yb3mk
20 Sep 19
Roxadustat Approved in Japan for the Treatment of Anemia Associated with Chronic Kidney Disease in Dialysis Patients
9:00am